Hans Garmo

King’s College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (15)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Martin Eklund

Associate professor

Karolinska Institutet

SWEDEN

View details

E Lin

Uppsala University

SWEDEN

View details

Jan Adolfsson

Karolinska Institutet

SWEDEN

View details

Kerri Beckmann

University of South Australia

AUSTRALIA

View details

Johan Styrke

Umeå Universitet Medicinska fakulteten

SWEDEN

View details

Lars Holmberg

King’s College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hans Garmo

Research Interests

Explore related searches

Contact this professor

Articles (15)

Family History of Early Onset or Lethal Prostate Cancer and the Risk of Prostate Cancer Death in Sweden

Sociodemographic disparities in incidence rates of advanced and low-risk prostate cancer as a proxy for diagnostic activity

Risk of prostate cancer death in men diagnosed with prostate cancer at cystoprostatectomy. A nationwide population-based study

Temporal trend in risk of prostate cancer death in men with favourable-risk prostate cancer

Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base Sweden

Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in Sweden

Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists

Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study

Mortality in men with castration‐resistant prostate cancer—A long‐term follow‐up of a population‐based real‐world cohort

Time on treatment with abiraterone and enzalutamide in the Patient-overview Prostate Cancer in The National Prostate Cancer Register of Sweden

Short-term ciprofloxacin prophylaxis for prostate biopsy and risk of aortic aneurysm. Nationwide, population-based cohort study

Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in Sweden

PSA testing patterns in a large Swedish cohort before the implementation of organized PSA testing

Adherence to guidelines for androgen deprivation therapy after radical prostatectomy: Swedish population-based study

Radical radiotherapy for prostate cancer: patterns of care in Sweden 1998–2016

Collaborators (6)

Martin Eklund

E Lin

Jan Adolfsson

Kerri Beckmann

Johan Styrke

Lars Holmberg

Make your next move.

Hans Garmo

Research Interests

Explore related searches

Contact this professor

Articles (15)

Family History of Early Onset or Lethal Prostate Cancer and the Risk of Prostate Cancer Death in Sweden

Sociodemographic disparities in incidence rates of advanced and low-risk prostate cancer as a proxy for diagnostic activity

Risk of prostate cancer death in men diagnosed with prostate cancer at cystoprostat­ectomy. A nationwide population-based study

Temporal trend in risk of prostate cancer death in men with favourable-risk prostate cancer

Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base Sweden

Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in Sweden

Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists

Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study

Mortality in men with castration‐resistant prostate cancer—A long‐term follow‐up of a population‐based real‐world cohort

Time on treatment with abiraterone and enzalutamide in the Patient-overview Prostate Cancer in The National Prostate Cancer Register of Sweden

Short-term ciprofloxacin prophylaxis for prostate biopsy and risk of aortic aneurysm. Nationwide, population-based cohort study

Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in Sweden

PSA testing patterns in a large Swedish cohort before the implementation of organized PSA testing

Adherence to guidelines for androgen deprivation therapy after radical prostatectomy: Swedish population-based study

Radical radiotherapy for prostate cancer: patterns of care in Sweden 1998–2016

Collaborators (6)

Martin Eklund

E Lin

Jan Adolfsson

Kerri Beckmann

Johan Styrke

Lars Holmberg

Make your next move.

Risk of prostate cancer death in men diagnosed with prostate cancer at cystoprostatectomy. A nationwide population-based study